Page 3 - Laura Gault News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Laura gault. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Laura Gault Today - Breaking & Trending Today

Sage Therapeutics trims staff by 40% following depression drug setback

The cuts, including several C-suite exits, come in the wake of the FDA’s decision not to approve Sage and partner Biogen’s drug for major depression. ....

Marc Goodman , Laura Gault , Al Robichaud , Jim Doherty , Barry Greene , Chris Benecchi , Drug Administration , Sage Therapeutics , Mike Quirk ,

FDA Approves New Pill for Postpartum Depression

The FDA just approved zuranolone, a new medication to treat postpartum depression. The drug is in pill form and meant to be taken once a day for 14 days for fast-acting treatment. ....

United States , Laura Gault , Christopher Zahn , Elizabethm Fitelson , Health Equity , Columbia University Department Of Psychiatry , Sage Therapeutics Inc , Biogen Inc , Drug Administration , Women Program , American College Of Obstetrics , Sage Therapeutics , Clinical Practice , American College , Novel Approach , Depression Treatment , Columbia University Department , Long Acting Treatment , Huge Step , Postpartum Medicine , Could Be Available ,

EMA grants ODD to Sage Therapeutics' SAGE-718 to treat Huntington's disease

EMA has granted Orphan Drug Designation to biopharmaceutical company Sage Therapeutics’ SAGE-718 for the treatment of Huntington’s disease (HD). ....

Laura Gault , Orphan Drug Designation ,

Sage Therapeutics, Inc.: Sage Therapeutics Announces European Medicines Agency Granted SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the European Medicines Agency (EMA) granted Orphan Drug ....

Dennis Riedl , Helen Rubinstein , Matthew Henson , Laura Gault , Exchange Commission , Sage Therapeutics Inc , European Medicines Agency , Sage Therapeutics , Orphan Drug Designation , Chief Medical Officer , Protocol Assistance , Fast Track Designation , Private Securities Litigation Reform Act ,

Sage Therapeutics, Inc. (NASDAQ:SAGE) Q4 2022 Earnings Call Transcript

Operator: Good morning. Welcome to the Sage Therapeutics Fourth Quarter and Full-Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. ....

United States , Chris Benecchi , Kimi Iguchi , Barry Greene , Helen Rubinstein , Jim Doherty , Tazeen Ahmad , Laura Gault , Sage Therapeutics Inc , Health Photo , Brain Health , Sage Therapeutics , Call Transcript February , Sage Therapeutic Fourth Quarter , Results Conference , Investor Relations , Sage Therapeutic , Chief Executive Officer , Chief Financial Officer , Chief Medical Officer , Major Depressive Disorder , Postpartum Depression , Sasun Bughdaryan , Fast Track , Performing Dividend Stocks , Performing Consumer Staples Stocks ,